<?xml version="1.0" encoding="UTF-8"?>
<p id="Par59">The hRV incidence in immunocompromised children undergoing chemotherapy has been found to be up to 22.3% on the 100th day of treatment [
 <xref ref-type="bibr" rid="CR36">36</xref>], and hRV is by far the most common respiratory pathogen isolated in immunocompromised children undergoing chemotherapy treatment [
 <xref ref-type="bibr" rid="CR16">16</xref>].
</p>
